According to the new market research report "Molecular Quality Controls Market by Product (Independent, Instrument Specific (PCR, DNA Sequencing)), Application (Infectious Diseases Diagnostic), Analyte Type, End User (Hospitals, Diagnostic Lab) – Global Forecast to 2026", published by MarketsandMarkets™, the global market to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period.
Browse in-depth TOC
on "Molecular
Quality Controls Market"
163 – Tables
61 – Figures
275 – Pages
Download PDF
Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523
The growth of this market is primarily driven by factors such as
the rising adoption of third-party quality controls, increasing number of
accredited clinical laboratories, the rising demand for external quality
assessment support, increasing government funding to support genomics projects,
increasing demand for personalized medicines and declining costs of sequencing
procedures and increasing prevalence of infectious diseases, cancer &
genetic diseases.
Independent controls
accounted for the largest share of the molecular quality controls market in
2020
Based on product, the molecular quality control market is
segmented into Independent Controls and Instrument Specific Controls. The
Independent control segment accounted for the largest share of the market in
2020. The increasing number of accredited laboratories and mandates for the use
of quality controls from regulatory bodies to ensure the accuracy of diagnostic
test results are driving the growth of the molecular quality control products
market.
Single-analyte
controls to account for the largest share of the market during the forecast
period
Based on analyte type, the market is segmented into
single-analyte controls and multi-analyte controls. Single-analyte controls
dominated the molecular quality controls market in 2020 due to the significant
use of singleplex assays in hospitals and the advantages associated with the
use of single-analyte controls, such as simple analysis & interpretation
and low risk of cross-reactivity.
Request Sample
Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=82625523
Infectious Disease
Diagnostic to account for the largest share of the market during the forecast
period
Based on application, the molecular quality control market is
segmented into infectious disease diagnostics, oncology testing, genetic
testing, and other applications. The infectious disease diagnostics segment
accounted for the largest share of the molecular quality controls market in
2020. The large share of this segment is attributed to the development of
advanced assays for infectious diseases, a significant increase in the
prevalence of infectious diseases, and the rising awareness about the effective
use of molecular diagnostic technologies to control the occurrence and spread
of infectious diseases.
Diagnostic
Laboratories to account for the largest share of the market during the forecast
period
The key end users of molecular quality controls studied in this
report include diagnostic laboratories, hospitals, IVD Manufacturers and CROs
Academic & Research Institutes, and other end users. The Diagnostic
Laboratories segment accounted for the largest share of the market in 2020,
increasing number of accredited diagnostic laboratories to provide growth
opportunities in the coming years.
The APAC molecular
quality controls market is projected to grow at the highest rate during the
forecast period.
The molecular quality control market is segmented into five
major regions, namely, North
America, Europe, Asia Pacific, Latin America,
and the Middle
East & Africa. In 2020, North America was
the largest regional market for molecular quality controls due to the developed
healthcare system in the US and Canada, the presence of many
leading molecular quality control product manufacturers in the region, and the
easy accessibility to technologically advanced products in the region. However,
the market in the Asia
Pacific is estimated to grow at the highest CAGR during the
forecast period. The presence of emerging economies such as China and India and
the significant demand for high-quality and accurate diagnostic tests from the
large patient population in this region are the major factors supporting the
growth of the Asia
Pacific market.
The prominent players in the molecular quality controls market
are F. Hoffmann-La Roche Ltd. (Switzerland),
Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories
Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics
(UK), SERO AS (Norway),
Anchor Molecular (US), Ortho-Clinical Diagnostics, Inc. (US), Quidel
Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea),
ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US),
Microbiologics, Inc. (US), Microbix Biosystems Inc. (Canada), SpeeDx Pty. Ltd. (Australia),
Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Browse Related Reports:
Molecular
Diagnostics Market by Product & Service(Reagents, Kits, PoC &
Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology,
Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic
Labs)-Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
No comments:
Post a Comment